Genistein, a phytoestrogenic isoflavonoid, has been found to partially exert its tumour‐suppressive effect by inhibiting the expression of CDC20 in GBM, hepatocellular carcinoma and breast cancer cells [44]. Here, CDC20 is linked to glioblastoma.